http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_28ecb43e30ef5e284fdaf13931ff5984
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Nebiyou Bekele Bekele |
| name | B. Nebiyou Bekele B Nebiyou Bekele |
| given-name | B Nebiyou B. Nebiyou B B. |
| organization-name | 3Biostatistics and Applied Mathematics, and University of Texas M. D. Anderson Cancer Center , Houston , USA Authors' Affiliations: Departments of 1Pathology, 2Thoracic/Head and Neck Medical Oncology, 3Biostatistics, and 4Thoracic Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 5Hamon Center for Therapeutic Oncology Research and Departments of 6Internal Medicine and 7Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas; and 8Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland 4Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas Biostatistics, and 6Biostatistics and Applied Mathematics, M. D. Anderson Cancer Center, Houston, Texas From the Departments of Leukemia, Hematopathology, Stem Cell Transplantation and Cellular Therapy, and Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Division of Hematological Malignancies, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD. From the Departments of Leukemia and Biostatistics and Applied Mathematics, University of Texas, M. D. Anderson Cancer Center, Houston, TX; and the Department of Hematopathology, Nichols Institute, Quest Diagnostics, San Juan Capistrano, CA. Authors' Affiliations: Departments of 1Thoracic/Head and Neck Medical Oncology, 2Pathology, and 3Biostatistics, The University of Texas M.D. Anderson Cancer Center, and 4The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas Division of Quantitative Sciences, M. D. Anderson Cancer Center, Houston, TX, USA From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX. Gilead Sciences, Foster City, California, USA From the Departments of Thoracic/Head and Neck Medical Oncology, Clinical Cancer Prevention, Pathology, and Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Institut Gustave Roussy, Villejuif, France; and Winship Cancer Institute, Emory University, Atlanta, GA From The University of Texas M. D. Anderson Cancer Center; The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX; and the National Cancer Institute, Bethesda, MD. Authors' Affiliations: Departments of 1Neuro-Oncology, 2Thoracic/Head and Neck Medical Oncology, and 3Applied Mathematics and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas; 4university of California, Los Angeles, California; 5University of Wisconsin, Madison, Wisconsin; 6Memorial Sloan–Kettering Cancer Center, New York, New York; 7Radiation Oncology Branch, National Cancer Institute; 8Cancer Therapy Evaluation Program, National Cancer Institute; 9University of California, San Francisco, California; and 10Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts 2Biostatistics, and Authors' Affiliations: Departments of 1Radiation Oncology, 2Biostatistics, 3Pathology, and 4Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 5Department of Oncology, University of Oxford, Oxford, United Kingdom From the Section of Health Services Research, Department of Biostatistics; Departments of Thoracic/Head & Neck Medical Oncology, General Internal Medicine, Ambulatory Treatment and Emergency Care, Breast Medical Oncology, and Sarcoma Medical Oncology; Department of Infectious Diseases and Infection Control, Quantitative Sciences Division, The University of Texas M.D. Anderson Cancer Center, Houston, TX; New York Lung Cancer Alliance, New York, NY; and Massachusetts General Hospital, Boston, MA From the Departments of Leukemia, Bioimmunotherapy, Laboratory Medicine, and Biostatistics, The University of Texas, M.D. Anderson Cancer Center, Houston, TX. 3Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas and 3Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas From the Department of Biostatistics & Applied Mathematics, and Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; and Research Institute and Hospital, National Cancer Center Korea, Gyeonggi-do, Republic of Korea 3Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; Biostatistics and Applied Mathematics 2Biostatistics and Applied Mathematics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 2Biostatistics and Applied Mathematics, Department of Biostatistics, Gilead Sciences Inc., Foster City, CA, USA Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA 2Biostatistics and Applied Mathematics, and Department of Biostatistics, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA From the Mayo Clinic, Rochester, MN; M. D. Anderson Cancer Center, Houston, TX; Division of Hematology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, University of Pavia, Pavia, Italy; Weill-Cornell Medical Center, New York, NY; Medical University of Vienna, Vienna, Austria; UCLA Medical Center, Los Angeles, CA; Hospital Clinic, Institut d'Investigatacions Biomedique, University of Barcelona, Barcelona, Spain; Mayo Clinic, Jacksonville, FL; Fred Hutchinson Cancer... 2Department of Biostatistics, University of Texas M. D. Anderson Cancer Center, Houston, Texas and |
Incoming Links
Total number of triples: 130.